Rimonabant blocks the expression but not the development of locomotor sensitization to nicotine in rats

Psychopharmacology

Volumn 198, Issue 4, 2008, Pages 461-466

  Kelsey, John E ^a   Calabro, Siena ^a  

^a BATES COLLEGE   (United States)

Author keywords

Cannabinoids; CB1 receptors; Locomotor sensitization; Nicotine; Rats; Rimonabant

Indexed keywords

NICOTINE; RIMONABANT; SODIUM CHLORIDE;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RAT; SENSITIZATION;

ANALYSIS OF VARIANCE; ANIMALS; BODY WEIGHT; CUES; INJECTIONS, INTRAPERITONEAL; MALE; MOTOR ACTIVITY; NICOTINE; NICOTINIC AGONISTS; PIPERIDINES; PYRAZOLES; RATS; RATS, LONG-EVANS; RECEPTOR, CANNABINOID, CB1;

EID: 44449093148     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-007-0913-x     Document Type: Article

References (40)

1. Arnold JC (2005) The role of endocannabinoid transmission in cocaine addiction. Pharmacol Biochem Behav 81:396-406
2. Arnone M, Maruani J, Chaperon F, Thiebot MH, Poncelet M, Soubrie P, Le Fur G (1997) Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology (Berl) 132:104-106
3. 1 receptor (CB1R) antagonists as potential pharmacotherapies for drug abuse disorders. Behav Pharmacol 16:275-296
4. Berridge KC, Robinson TE (1998) What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 28:309-369
5. 1) receptors in the establishment of place conditioning in rats. Psychopharmacology (Berl) 135:324-332
6. Cippitelli A, Bilbao A, Hansson AC, del Arco I, Sommer W, Heilig M, Massi M, Bermudez-Silva FJ, Navarro M, Ciccocioppo R, de Fonseca FR (2005) Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats. Eur J Neurosci 21:2243-2251
7. Clarke PB, Kumar R (1983) The effects of nicotine on locomotor activity in non-tolerant and tolerant rats. Br J Pharmacol 78:329-337
8. 1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behav Pharmacol 13:451-463
9. 1 receptor antagonists for the treatment of nicotine addiction. Pharmacol Biochem Behav 81:387-395
10. 1) receptor antagonist, rimonabant (SR141716). Neuropsychopharmacology 30:145-155
11. 1receptors control conditioned drug seeking. Trends Pharmacol Sci 26:420-426
12. De Vries TJ, Shaham Y, Homberg JR, Crombag H, Schuurman K, Dieben J, Vanderschuren LJ, Schoffelmeer AN (2001) A cannabinoid mechanism in relapse to cocaine seeking. Nat Med 7:1151-1154
13. De Vries TJ, Homberg JR, Binnekade R, Raaso H, Schoffelmeer AN (2003) Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats. Psychopharmacology (Berl) 168:164-169
14. De Vries TJ, de Vries W, Janssen MC, Schoffelmeer AN (2005) Suppression of conditioned nicotine and sucrose seeking by the cannabinoid-1 receptor antagonist SR141716A. Behav Brain Res 161:164-168
15. Deroche V, Le Moal M, Piazza PV (1999) Cocaine self-administration increases the incentive motivational properties of the drug in rats. Eur J Neurosci 11:2731-2736
16. 1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats. Psychopharmacology (Berl) 183:394-403
17. 1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in rats. Behav Brain Res 104:141-146
18. Fattore L, Spano MS, Cossu G, Deiana S, Fratta W (2003) Cannabinoid mechanism in reinstatement of heroin-seeking after a long period of abstinence in rats. Eur J Neurosci 17:1723-1726
19. Filip M, Golda A, Zaniewska M, McCreary AC, Nowak E, Kolasiewicz W, Przegalinski E (2006) Involvement of cannabinoid CB1 receptors in drug addiction: effects of rimonabant on behavioral responses induced by cocaine. Pharmacol Rep 58:806-819
20. 1 receptors are involved in motivational effects of nicotine in rats. Psychopharmacology (Berl) 181:722-734
21. Forget B, Barthelemy S, Saurini F, Hamon M, Thiebot MH (2006) Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats. Psychopharmacology (Berl) 189:59-69
22. Gardner EL (2005) Endocannabinoid signaling system and brain reward: emphasis on dopamine. Pharmacol Biochem Behav 81:263-284
23. Kelsey JE, Willmore EJ (2006) Electrolytic lesions of the nucleus accumbens enhance locomotor sensitization to nicotine in rats. Behav Neurosci 120:600-611
24. Kelsey JE, Beer T, Lee E, Wagner A (2002) Low doses of dizocilpine block the development and subsequent expression of locomotor sensitization to nicotine in rats. Psychopharmacology (Berl) 161:370-378
25. Ksir C, Hakan R, Hall DP Jr, Kellar KJ (1985) Exposure to nicotine enhances the behavioral stimulant effect of nicotine and increases binding of [3H]acetylcholine to nicotinic receptors. Neuropharmacology 24:527-531
26. 1 antagonist, blocks nicotine-conditioned place preferences. NeuroReport 15:2139-2143
27. Le Foll B, Goldberg SR (2005) Control of the reinforcing effects of nicotine by associated environmental stimuli in animals and humans. Trends Pharmacol Sci 26:287-293
28. Lesscher HM, Hoogveld E, Burbach JP, van Ree JM, Gerrits MA (2005) Endogenous cannabinoids are not involved in cocaine reinforcement and development of cocaine-induced behavioural sensitization. Eur Neuropsychopharmacol 15:31-37
29. Lett BT (1989) Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology 98:357-362
30. Maldonado R, Valverde O, Berrendero F (2006) Involvement of the endocannabinoid system in drug addiction. Trends Neurosci 29:225-232
31. Navarro M, Carrera MR, Fratta W, Valverde O, Cossu G, Fattore L, Chowen JA, Gomez R, del Arco I, Villanua MA, Maldonado R, Koob GF, Rodriguez de Fonseca F (2001) Functional interaction between opioid and cannabinoid receptors in drug self-administration. J Neurosci 21:5344-5350
32. Norwood CS, Cornish JL, Mallet PE, McGregor IS (2003) Pre-exposure to the cannabinoid receptor agonist CP 55940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats. Eur J Pharmacol 465:105-114
33. Overton DA (1964) State-dependent or "dissociated" learning produced with pentobarbital. J Comp Physiol Psychol 57:3-12
34. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D et al (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244
35. 1 receptor antagonist, SR 141716, of alcohol deprivation effect in alcohol-preferring rats. Eur J Pharmacol 443:95-97
36. Singh ME, Verty AN, McGregor IS, Mallet PE (2004) A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphine. Brain Res 1026:244-253
37. Solinas M, Panlilio LV, Antoniou K, Pappas LA, Goldberg SR (2003) The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4- dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats. J Pharmacol Exp Ther 306:93-102
38. Vanderschuren LJ, Kalivas PW (2000) Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) 151:99-120
39. Vigano D, Valenti M, Cascio MG, Di Marzo V, Parolaro D, Rubino T (2004) Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine. Eur J Neurosci 20:1849-1857
40. Woolverton WL, Cervo L, Johanson CE (1984) Effects of repeated methamphetamine administration on methamphetamine self-administration in rhesus monkeys. Pharmacol Biochem Behav 21:737-741